Reaction profile

The FDA adverse-event record for lung tumour

123 FDA adverse-event reports reference lung tumour (VeDDRA 1917). Plate codes and volume neighbourhood below; species, breeds, and drugs follow.

#1294 of 2,481
by report volume (all reactions)
123
reports citing this reaction
56.1%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Lung tumour has 123 reports now versus 119 in that prior snapshot: 4 more (3.4%).

Report change
+4
Death-coded reports
+2
Death-coded share
−0.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Lung tumour changes

FDA AER · VeDDRA plate

Code 1917 VOL-LOW

VOL-LOW · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-LOW 123 reports
  • DEATH-HOT 56.1%
  • MID-PACK #1294/2481
  • PHOTO-FINISH Birth defect
  • SPECIES-DOG Dog · 102
  • DRUG-LEAD Oclacitinib Malea… · 26
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Birth defect (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Report-volume neighbourhood around Lung tumour

Highest and lowest poles plus nearest volume peers, not a full 2,500-reaction corpus board reprint.

Vomiting · highest174348Birth defect · near123Hypomagnesaemic condi… · near123Joint ligament disord… · near123Lens disorder NOS · near123Lung tumour · this reaction123Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Lung tumour

Lung tumour: high death-coded share in the FDA AER plate

Signature read: Lung tumour's 56.1% death-coded share is among the highest in the openFDA reaction corpus. Report volume sits in the middle third of the reaction corpus. Death-coded share is upper-third: 69 of 123 reports (56.1% of named reports). Nearest volume peer: Birth defect (±0 reports). Lead species Dog (102). Lead co-reported drug Oclacitinib Maleate (26).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 102
Cat 21

Breeds Most Affected

Domestic Shorthair 10
Retriever - Golden 9
Boxer (German Boxer) 8
Retriever - Labrador 7
Crossbred Canine/dog 5
Dog (unknown) 5
Shepherd Dog - Australian 4
Pit Bull 4
Terrier - Bull - American Pit 4
Shih Tzu 3

Associated Drugs

Oclacitinib Maleate 26
Milbemycin Oxime + Spinosad 20
Bedinvetmab 14
Gabapentin 11
Trilostane 8
Maropitant Citrate 8
Carprofen 7
Fluralaner Chew Tablets 6
Anti-Il31 Mab Mcs Lot #1283563 6
Frunevetmab 6
Cefovecin 5
Ivermectin + Pyrantel As Pamoate Salt 5
Tramadol 4
Prednisone 4
Spinosad 4
Afoxolaner 4
Imidacloprid + Moxidectin 3
Polysulfated Glycosaminoglycan 3
Selamectin 3
Sarolaner 3

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Lung tumour, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

Similar report volume

Nearest other reactions by FDA report count (123 here).

Similar death-coded share

Nearest other reactions by death-coded share (56.1% here), distinct from the volume row.

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Lung tumour (#1294 of 2,481 by report volume); death-coded 56.1%. PlainBreed reaction plate · death-coded share stamp 56.1% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →